`

Invivyd

Biotechnology Research

Last Updated: November 20, 2025
Sign Up to View More
Revenue
$25.38M
funding-icon Total Funding
$466.00M
Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs
Recent News

Frequently Asked Questions About Invivyd

What does Invivyd do?+

Invivyd, Inc. (Nasdaq: IVVD) is a commercial-stage company is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases. Leveraging state-of-the-art viral surveillance, predictive modeling, and advanced antibody engineering techniques, we are taking a platform-based approach to the continuous discovery and optimization of monoclonal antibody candidates designed to protect the vulnerable from serious viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more

What is Invivyd's industry? +

Invivyd operates in the Biotechnology research industry.

What is Invivyd's revenue? +

Invivyd's revenue is $25.38m

What is Invivyd's company size? +

Invivyd has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free